The basis for modeling progressive multifocal leukoencephalopathy pathogenesis

Abstract

Insights

Progressive multifocal leukoencephalopathy (PML) is rare despite widespread JC virus infection, indicating significant biological barriers. Understanding these barriers is crucial for managing PML risks associated with new therapies.

Area of Science:

  • Neurovirology
  • Immunology
  • Pathogenesis of demyelinating diseases

Background:

  • Progressive multifocal leukoencephalopathy (PML) is a rare but serious demyelinating disease.
  • The increasing use of highly effective biological agents has heightened concerns regarding PML.
  • Understanding PML pathogenesis is critical for risk assessment and mitigation.

Discussion:

  • JC virus (JCV), a common human polyomavirus, is the causative agent of PML.
  • PML development requires overcoming multiple host, viral, and immunological barriers.
  • JCV requires promoter rearrangement for oligodendrocyte infection, representing a viral barrier.

Key Insights:

  • Cell-mediated immunity, specifically JC virus-specific cytotoxic T cells, is a primary immunological barrier against PML.
  • Despite high JCV seroprevalence, PML incidence is very low, underscoring the importance of these protective mechanisms.
  • Host factors influencing PML susceptibility remain largely uncharacterized.

Outlook:

  • Significant knowledge gaps persist regarding JCV biology and PML pathogenesis.
  • Current understanding provides a foundation for developing predictive models and risk mitigation strategies.
  • Further research into JCV-PML mechanisms will improve patient care and therapeutic safety.

Related Concept Videos

Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Bacterial Meningitis II: Pathophysiology01:26

Bacterial Meningitis II: Pathophysiology

Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...